The Jackson Laboratory and AbTherx to Boost Therapeutic Antibody Discovery
The Jackson Laboratory (JAX) has forged a strategic partnership with AbTherx to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.
Antibody Discovery | 13/05/2024 | By Aishwarya | 418
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy